Heart failure with preserved ejection fraction (HFpEF) is a disease for which there is no
definite and effective treatment, and the number of patients is more than 50% of heart failure …

Introduction: Heart failure with preserved ejection fraction (HFpEF) is associated with
disrupted intestinal epithelial function, resulting from intestinal congestion. Intestinal …

Heart failure (HF) is a sophisticated syndrome with structural or functional impairment of
ventricular filling or ejection of blood, either causing symptoms and signs or being …

Heart failure (HF) is a debilitating disease with a significant clinical and economic impact
worldwide. Multiple factors seem to increase the risk of developing HF, such as …

Objective: The purpose of this review is to stress the complicated interactions between the
microbiota and the development of heart failure. Moreover, the feasibility of modulating …

Gut microbiome (GMB) has been increasingly recognized as a contributor to development
and progression of heart failure (HF), immune-mediated subtypes of cardiomyopathy …

The association between gut microbiota and the development of heart failure has become a
research hotspot in recent years and the impact of gut microbiota on heart failure has …

Despite the development of new drugs and therapeutic strategies, mortality and morbidity
related to heart failure (HF) remains high. It is also the leading cause of global mortality …

Heart failure (HF) remains a significant global health challenge, affecting millions of
individuals worldwide and posing a substantial burden on healthcare systems. HF is a …

Although the mechanism of the occurrence and development of heart failure has been
continuously explored in the past ten years, the mortality and readmission rate of heart …